The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

( MENAFN - Mid-East Info) The Retina clinic London will showcase cutting-edge innovations in the diagnosis, monitoring, and ...

Diabetes extends far beyond blood sugar management, affecting vital organs throughout the body. This chronic condition, ...

Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...

The "Diabetic Retinopathy - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an overview of trial numbers and their average ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Ocular Therapeutix (OCUL) plans to advance AXPAXLI in non-proliferative diabetic retinopathy, NPDR, and the Company’s strategic outlook for ...